The syntheses and the solid state structural and spectroscopic solution characterizations of VO(Me-acac)2 and VO(Et-acac)2 (where Me-acac is 3-methyl-2,4-pentanedionato and Et-acac is 3-ethyl-2,4-pentanedionato) have been conducted since both VO(acac)2 and VO(Et-acac)2 have long-term in vivo insulin-mimetic effects in streptozotocin-induced diabetic Wistar rats. X-ray structural characterizations of VO(Me-acac)2 and VO(Et-acac)2 show that both contain five-coordinate vanadium similar to the parent VO(acac)2. The unit cells for VO(Et-acac)2 and VO(Me-acac)2 are both triclinic, P1, with a = 9.29970(10) A, b = 13.6117(2) A, c = 13.6642(2) A, alpha = 94.1770(10) degrees, beta = 106.4770(10) degrees, gamma = 106.6350(10) degrees for VO(Et-acac)2 and a = 7.72969(4) A, b = 8.1856(5) A, c = 11.9029(6) A, alpha = 79.927(2) degrees, beta = 73.988(2)degrees, gamma = 65.1790(10)degrees for VO(Me-acac)2. The total concentration of EPR-observable vanadium(IV) species for VO(acac)2 and derivatives in water solution at 20 degreesC was determined by double integration of the EPR spectra and apportioned between individual species on the basis of computer simulations of the spectra. Three species were observed, and the concentrations were found to be time, pH, temperature, and salt dependent. The three complexes are assigned as the trans-VO(acac)2.H2O adduct, cis-VO(acac)2.H2O adduct, and a hydrolysis product containing one vanadium atom and one R-acac- group. The reaction rate for conversion of species was slower for VO(acac)2 than for VO(malto)2, VO(Et-acac)2, and VO(Me-acac)2; however, in aqueous solution the rates for all of these species are slow compared to those of other vanadium species. The concentration of vanadium(V) species was determined by 51V NMR. The visible spectra were time dependent, consistent with the changes in species concentrations that were observed in the EPR and NMR spectra. EPR and visible spectroscopic studies of solutions prepared as for administration to diabetic rats documented both a salt effect on speciation and formation of a new halogen-containing complex. Compound efficacy with respect to long-term lowering of plasma glucose levels in diabetic rats traces the concentration of the hydrolysis product in the administration solution.

Reaction of [V(IV)OL(1)(Im)] (H(2)L(1) = S-methyl-3-((2-hydroxyphenyl)methyl)dithiocarbazate) with [V(V)OL(OCH(3))] allows isolation of (ImH)[L(1)OV-(&mgr;-O)-VOL] complexes 2 (H(2)L = H(2)L(2) = S-methyl-3-((5-bromo-2-hydroxyphenyl)methyl)dithiocarbazate) and 3 (H(2)L = H(2)L(1)), one of which (2) has ligand asymmetry not previously known in this type of complex. In the solid state, (ImH)[L(1)OV-(&mgr;-O)-VOL(2)] (2) provides an example of a divanadium(IV,V) compound with a syn angular [V(2)O(3)](3+) core structure that exhibits crystallographically imposed mirror symmetry due to static disorder. Crystals of 2 are orthorhombic, space group Pnma, with a = 10.740(2) Å, b = 18.912(4) Å, c = 17.163(4) Å, and Z = 4. In toluene at room temperature, both 2 and 3 have 8-line EPR spectra, characteristic of trapped-valence structure. When acetonitrile is added to these solutions, the spectra reveal 15-line features with asymmetric distortions that smooth out with the lowering of temperature. This probably has its origin in a solvent-dependent equilibrium involving two magnetically inequivalent structural forms of the divanadium(IV,V) compound, with syn angular and anti linear structures of the [V(2)O(3)](3+) core. Variable temperatures (298-220 K) (51)V NMR spectroscopic studies in solution also support this view. In acetonitrile, both 2 and 3 exhibit an intervalence transfer band in the near-IR region at ca. 970 nm (epsilon, 1600 and 1480 M(-)(1) cm(-)(1) for 2 and 3, respectively) and they undergo one-electron reversible oxidation at ca. 0.40 V (vs SCE) due to the V(IV)V(V)/V(V)V(V) couple.